Connect2

Lord Triesman was set up

jewellerymaker — Mon, 17 May 2010 15:06:38 +0000

Lord Triesman has been set up by the biased Tory Press, his private conversation with a secretary with whom he’s alleged to “have had an affair with” recorded without his permission,a conversation in which all sorts of football questions were asked, including about Terry and others (was she reading from a list?),texts kept from Jan 2008 and the recordings done around the time of the “John Terry affair allegations” NOT very recently as the newspapers and TV news are portraying.

David Triesman, Baron Triesman – Wikipedia, the free encyclopedia

Dave Richards has been overlooked because he’s not a Tory:

dave-richards-resigns-england-world-cup

In place are two temporary managers who are biased for the Tories:

David Sheepshanks – Wikipedia, the free encyclopedia

Roger Burden – New director appointments

I wonder if Lord Coe will be interested in the position?





















The Daily Mail is blaming Lord Triesman, the FA wanted the paper not to publish it, but they went and did it anyway and added further salacious gossip into the story

(she kept all the text messages and wrote indepth on her blog so it must be true!,gossip is believed automatically and the accused has not chance to put their case forward in a “trial by newspaper”

,the newspaper is at fault for ignoring advice and going ahead for the sake of making money from salacious articles and damaging the English FA’s reputation



by the way Triesman was a labour peer and the two chaps who are temporarily in charge are tories,look them up on wikipedia, i bet Lord Coe (tory)or someone similar gets the job, you can pretend its not political but it is really,so is the olympics.

FA chief Lord Triesman: Spain in bid to bribe World Cup referees | Mail Online

I noticed that article has been altered in places (removing the statement that the recording was made when he was minister for innovation etc. which was when the john terry scandal was in all the papers,not as if it was last week as the papers/tv news are portraas it was different when first added yesterday, (note 10.26am last updated under article title)

Is ‘Swine flu’ man made?

jewellerymaker — Tue, 25 Aug 2009 15:30:00 +0000

Startling New Evidence ‘Swine Flu’ Pandemic Is Man-Made

Swine flu vaccine link to Guillain Barre Syndrome

jewellerymaker — Sun, 16 Aug 2009 16:46:16 +0000

Check out this link:

Swine flu jab link to killer nerve disease: Leaked letter reveals concern of neurologists over 25 deaths in America | Mail Online

Id card con

jewellerymaker — Wed, 06 May 2009 11:57:00 +0000

It starts off with this picture::

Then leads on to these

Al-Qaeda terror plot to bomb Easter shoppers – Telegraph

12 Arrested In Very Serious Terror Plot In UK : Homeland Security News

Anti-terrorism police search Manchester park – Yahoo! News UK

12 arrested in North West terrorist raids all released without charge – Telegraph

What a surprise a month later,when everyone is preoccupied with swine flu this announcement is made

Manchester chosen for ID cards launch | UK | Reuters

This is what the home office has to say:ID cards | Home Office

Remember the old expressions ‘an englishmans home is his castle’ and ‘it’s a free country’, we’re on a dangerous and slippery slope towards a neo-nazi style nightmare future. All of this control has gone too far and is a betrayal of the values that our grandfathers fought for on the beaches of Normandy.

Relenza versus Tamiflu

jewellerymaker — Fri, 01 May 2009 10:40:24 +0000

Relenza is a medication designed to treat Influenza virus A and Influenza virus B. Relenza is the commercial name and only type of Zanamivir, and was the first neuraminidase inhibitor commercially developed.

Zanamivir was discovered in 1989 by scientists led by Mark von Itzstein at the Victorian College of Pharmacy in Melbourne. The discovery was funded initially by the Australian biotechnology company Biota and was part of Biota’s ongoing program to develop antiviral agents.

In 1990 licensing of zanamivir was sold to Glaxo, which is now known as GlaxoSmithKline (GSK). In 1999, the product was approved for marketing in the US and subsequently has been registered by GSK in a total of 70 countries. (GlaxoSmithKline News release, 2006) The approval of Relenza in the United States was controversial. In 1999 a Food and Drug Administration (FDA) advisory committee voted 13 to 4 not to approve the drug because of limited data on efficacy and safety concerns. The drug was approved later in 1999.^]

Both Influenza A and B cause illness, however Influenza A is the more virulent strain. Influenza A is responsible for both the common ‘seasonal flu’ and notable influenza pandemics such as the Spanish flu (1918).

Influenza, commonly known as the flu, is caused by a virus which targets the body’s respiratory cells and damages the lining of the respiratory tract, leading to swelling and inflammation of the tract. Influenza spreads rapidly by replicating itself inside the host cell, producing hundreds of copies of the virus in a short period. In approximately an hour the virus can destroy the host cell and propel its replications out into the body to find new host cells.

Relenza was designed to attack the infected host cells, preventing the virus from spreading throughout other cells in the body and thus reducing the amount of time the virus can survive.

Tamiflu, Relenza’s main competitor, was proven in 2006 to not be as effective at treating the Influenza viruses as Relenza. As a result in August 2006 Germany announced that it would buy 1.7 million doses of Relenza as part of its preparation strategy against bird flu.

Bulk orders of Tamiflu from the United Kingdom, France and other countries to cover 20% or more of their population are pushing Roche’s production capacity to the limit. But Relenza, claims only one percent of the growing flu drug market. The drug has suffered from bad marketing, according to a lawsuit that Biota, which gets a percentage of sales, is bringing against GlaxoSmithKline.

In clinical trials it was found that zanamivir was able to reduce the time to symptom resolution by 1.5 days if therapy was started within 48 hours of the onset of symptoms.

Relenza is a safe and effective treatment for influenza, but must be administered soon after the first symptoms appear. Six to 12 hours is ideal. In most countries the drugs can only be obtained with a doctor’s prescription, and usually the time taken to get a prescription renders them ineffective (Professor Graeme Laver,2007)

Although zanamivir (Relenza)was the first neuraminidase inhibitor to the market, it had only a few months lead over the second entrant, oseltamivir (Tamiflu), with an oral tablet formulation much preferred by patients and physicians.

Zanamivir is administered by inhaler and never attained a high popularity.

Relenza is at least as effective as Tamiflu and has fewer side effects, including nausea and headaches, according to an article published 13 August (Lancet 366, 533−534; 2005). The report, based on data compiled from the companies’ clinical trials and from subsequent studies, also says there is no evidence of resistance to Relenza, compared with resistance levels of up to 18% in those taking Tamiflu (Lancet 364, 759−765; 2004). The researchers recommend stockpiling both.(David Cyranoski, 2005)Tamiflu-resistant strains have also appeared in the European Union, which remain sensitive to Relenza^.

Swine flu cynic

jewellerymaker — Tue, 28 Apr 2009 16:01:02 +0000

Swine influenza (also swine flu) refers to influenza caused by any virus of the family Orthomyxoviridae, that is endemic to pig (swine) populations. Strains endemic in swine are called swine influenza virus (SIV), and all known strains of SIV are classified as Influenzavirus A (common) or Influenzavirus C (rare).Influenzavirus B has not been reported in swine. All three classes, Influenzavirus A, B, and C, are endemic in humans^].

People who work with poultry and swine, especially people with intense exposures, are at risk of infection from these animals if the animals carry a strain that is also able to infect humans. SIV can mutate into a form that allows it to pass from human to human.

The strain responsible for the 2009 swine flu outbreak is believed to have undergone this mutation.^[2]

In humans, the symptoms of swine flu are similar to those of influenza and of influenza-like illness in general.

The swine flu is susceptible to four drugs licensed in the United States, amantadine, rimantadine, oseltamivir and zanamivir, however, for the 2009 outbreak it is recommended it be treated under medical advice only with oseltamivir and zanamivir to avoid drug resistance.^[The vaccine for the human seasonal H1N1 flu does not protect against the swine H1N1 flu, even if the virus strains are the same specific variety, as they are antigenically very different

Swine flu in humans

People who work with poultry and swine, especially people with intense exposures, are at increased risk of zoonotic infection with influenza virus endemic in these animals, and constitute a population of human hosts in which zoonosis and reassortment can co-occur.^[Transmission of influenza from swine to humans who work with swine was documented in a small surveillance study performed in 2004 at the University of Iowa.This study among others forms the basis of a recommendation that people whose jobs involve handling poultry and swine be the focus of increased public health surveillance.^[The 2009 swine flu outbreak is an apparent reassortment of several strains of influenza A virus subtype H1N1, including a strain endemic in humans and two strains endemic in pigs, as well as an avian influenza

The CDC reports that the symptoms and transmission of the swine flu from human to human is much like that of seasonal flu. Common symptoms include fever, lethargy, lack of appetite and coughing, while runny nose, sore throat, nausea, vomiting and diarrhea have also been reported.It is believed to be spread between humans through coughing or sneezing of infected people and touching something with the virus on it and then touching their own nose or mouth^.

Swine flu cannot be spread by pork products, since the virus is not transmitted through food.The swine flu in humans is most contagious during the first five days of the illness although some people, most commonly children, can remain contagious for up to ten days. Diagnosis can be made by sending a specimen, collected during the first five days, to the CDC for analysis.^[

The origins of this new strain remain unknown. One theory is that Asian and European strains traveled to Mexico in migratory birds or in people, then combined with North American strains in Mexican pig factory farms before jumping over to farm workers.^[The earliest known human influenza A virus subtype H1N1 case was at a Mexican pig farm whose nearby neighbors had been complaining about the manure smell and flies.^]

Edgar Hernandez, 4, was suffering from ordinary influenza but laboratory testing has since shown that he had contracted human influenza A virus subtype H1N1. The boy went on to make a full recovery.

The Mexican health agency acknowledged that the original disease vector of the virus may have been flies multiplying in manure lagoons of pig farms near Perote, Veracruz, owned by Granjas Carroll,^[a subsidiary of Smithfield Foods.

The CDC recommends the use of Tamiflu (oseltamivir) or Relenza (zanamivir) for the treatment and/or prevention of infection with swine influenza viruses. The virus isolates that have been tested from the US and Mexico are however resistant to amantadine and rimantadine.^[If a person gets sick, antiviral drugs can make the illness milder and make the patient feel better faster. They may also prevent serious flu complications. For treatment, antiviral drugs work best if started soon after getting sick (within 2 days of symptoms).

Influenza A virus subtype H1N1

H1N1 is a subtype of influenzavirus A and the most common cause of influenza in humans. Some strains of H1N1 are endemic in humans, including the strain(s) responsible for the 1918 flu pandemic and the many strains that cause influenza worldwide each year. Other strains of H1N1 are endemic in pigs and in birds. The 1918 flu pandemic killed 50–100 million people worldwide from 1918 to 1919.^[

In the name H1N1 the "H" refers to the hemagglutinin protein, and the "N" refers to the neuraminidase proteinLow pathogenic H1N1 strains still exist in the wild today, causing roughly half of all flu infections in 2006.^[]

In March and April 2009, an outbreak of influenza-like illness in Mexico killed nearly 200 people, and in 20 of these people a new strain ofH1N1 was detected.^[As of April 27, the new strain was suspected to have infected more than 2,000 individuals worldwide (see 2009 swine flu outbreak). On April 27, 2009, the World Health Organization raised alertness from level 3 to level 4

Interesting links

2009 swine flu outbreak in the United States - Wikipedia, the free encyclopedia

Tamiflu. is currently marketed by Hoffmann-La Roche (Roche) and was developed by US-based Gilead Sciences

Gilead Sciences was originally formed under the name of "Oligogen, Inc." in August 1987 by Michael Riordan, a medical doctor who was 29 years old at the time. But the name of the company was changed to "Gilead Sciences" in 1988. Riordan looked to DonaldRumsfeld as a mentor in the business world and to navigate the political waters.

In January 1997, DonaldRumsfeld, a Board member since 1988, was appointed Chairman of the company.^[He stood down from the Board in January 2001 when appointed Secretary of Defense at the start of George W. Bush's first term as President. Federal disclosure forms indicate that Rumsfeld owns between USD$5 million and USD$25 million in Gilead stock. The rise in Gilead's share prices from USD$35 to USD$57 per share will have added between USD$2.5 million to USD$15.5 million to Rumsfeld's net worth.^[3]

In November 2005, George W. Bush urged Congress to pass $7.1 billion in emergency funding to prepare for the possible birdflu pandemic, of which one billion is solely dedicated to the purchase, and distribution of Tamiflu.

UPDATE 3-Flu a windfall for some drugmakers, shares jump